Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 27 citing Shoji: Receptor for advanced glycation end products is involved in impaired angiogenic response.... (0.09 sec) 

RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases


H Koyama, H Yamamoto, Y Nishizawa - Molecular Medicine, 2007 - pubmedcentral.nih.gov
Receptor for advanced glycation end-products (RAGE) is known to be involved in
microvascular complications in diabetes. RAGE is also profoundly associated with
macrovascular complications in diabetes through regulation of ...
Cited by 27 - Related articles - BL Direct - All 6 versions

Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis …

- sherbornegibbs.com [PDF] 
N Katakami, M Matsuhisa, H Kaneto, TA … - Diabetes & Vascular Disease Research, 2008 - dvr.sagepub.com
Page 1. http://dvr.sagepub.com Diabetes and Vascular Disease Research DOI:
10.3132/dvdr.2008.031 2008; 5; 190 Diab Vasc Dis Res Yoshimitsu Yamasaki ...
Cited by 23 - Related articles - All 8 versions

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development …

- nih.gov
A Soro-Paavonen, A Watson, J Li, K Paavonen … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—Although diabetic apoE −/− mice showed increased plaque
accumulation (14.9 ± 1.7%), diabetic RAGE −/− /apoE −/− mice had
significantly reduced atherosclerotic plaque area (4.9 ± 0.4%) to levels ...
Cited by 22 - Related articles - All 9 versions

Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in …

- ahajournals.org
B Luo, Y Soesanto, DA McClain - Arteriosclerosis, thrombosis, and vascular biology, 2008 - Am Heart Assoc
Methods and Results— In a mouse aortic ring assay, elevated O-GlcNAc levels
induced by high-fat diet, streptozotocin-induced diabetes, or in vitro
glucosamine treatment were associated with impaired angiogenesis. In ...
Cited by 8 - Related articles - All 6 versions

Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies

- oxfordjournals.org
G Spinetti, N Kraenkel, C Emanueli, P … - Cardiovascular Research, 2008 - cardiovascres.oxfordjournals.org
Over the past two decades, extensive research has focused on arterial
remodelling in both physiological and pathological ageing. The concept now
describes the growth as well as the rearrangement of cellular components ...
Cited by 6 - Related articles - All 4 versions

Serum endogenous secretory RAGE level is an independent risk factor for the progression of …


N Katakami, M Matsuhisa, H Kaneto, T … - Atherosclerosis, 2009 - Elsevier
Japanese type 1 diabetic patients (n = 47, aged 24.0 ± 3.1 years) were enrolled
into a 4-year follow-up study and annual measurements of serum esRAGE and sRAGE
levels and IMTs were performed. At baseline, mean-IMT was inversely ...
Cited by 5 - Related articles - All 35 versions

Receptor for advanced glycation end product expression in experimental diabetic …


Y Wang, F vom Hagen, F Pfister, A Bierhaus … - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2008 - interscience.wiley.com
The advanced glycation end product (AGE)–receptor for AGE (RAGE) pathway is
involved in the pathogenesis of diabetic microvascular damage. The special
distribution of RAGE and its engagement has an impact on the development of ...
Cited by 5 - Related articles - BL Direct - All 6 versions

Exercise-induced expression of angiogenic growth factors in skeletal muscle and in …


R Kivelä, M Silvennoinen, M Lehti, S Jalava, … - Cardiovascular Diabetology, 2008 - cardiab.com
Of the proangiogenic factors, VEGF-A and VEGF receptor-2 (VEGFR-2) mRNA
expression increased significantly (P < 0.05) in healthy skeletal muscle 6 h
post exercise. VEGF-B also showed a similar trend (P = 0.08). No ...
Cited by 4 - Related articles - Cached - All 8 versions

Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial …


S Cherqui, KM Kingdon, C Thorpe, SM … - Molecular Therapy, 2007 - nature.com
Therapies that stimulate angiogenesis show promise in revascularization of
transplanted or ischemic tissues. Viral macrophage inflammatory protein-II
(vMIP-II) is encoded by human herpesvirus 8, and it can be both ...
Cited by 3 - Related articles - All 3 versions

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the …


KC Sourris, JM Forbes - Current Drug Targets, 2009 - ingentaconnect.com
Abstract: Diabetes, is a metabolic disorder characterised by chronic
hyperglycaemia, hypertension, dyslipidaemia, micro- albuminuria and
inflammation. Moreover, there are a number of complications associated with ...
Cited by 3 - Related articles - All 2 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google